Delivery Order SPE2DB22D3102-SPE2DB24FL0KA
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, a $1,081.34 firm fixed price delivery order, is for the provision of Pfizer COVID-19 vaccine doses in the 6-month to 4-year dosage form under the Emergency Use Authorization (EUA). The contract has a completion date of January 31, 2024. Amerisourcebergen Drug Corp, as the prime...
- This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,525.97 firm-fixed-price contract is for the supply of the Pfizer COVID-19 vaccine under the Emergency Use Authorization (EUA) for the 2023-2024 period, with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
- This federal contract award, valued at $1,129.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the procurement of Pfizer COVID-19 vaccines, with a period of performance from February 2025 to March 2025. The contract is a firm fixed-price arrangement and was not designated as a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,138.52 firm fixed price delivery order is for the supply of Pfizer's COVID-19 vaccine for the 2023-2024 period, under the Emergency Use Authorization (EUA). The award is not set-aside, and is delivered under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the...
- This is a $1,069.25 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,309,714 units of the Pfizer COVID-19 vaccine (0.9 mL) under an Emergency Use Authorization (EUA) over a period of 6 months to 4 years. The contract is a Firm Fixed Price (FFP) arrangement with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.80 firm fixed-price delivery order is for the procurement of Pfizer COVID-19 vaccine doses, with an ultimate completion date of December 23, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award, with a ceiling value of $1,129.80, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the procurement of COVID-19 vaccines, specifically Pfizer's COVID-19 vaccine, with an ultimate completion date of December 27, 2024. The contract is a Firm Fixed Price arrangement and is not designated as a set-aside. AmerisourceBergen holds a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 0.9ML doses of the Pfizer COVID-19 vaccine under an Emergency Use Authorization (EUA) from April 2023 to April 2024. The $1,525.97 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999.00 through...
- This federal contract award, valued at $3,407.31, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is a Delivery Order for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 timeframe, with a period of performance through November 18, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designations, indicating open competition. AmerisourceBergen holds a significant Indefinite...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The $3,207.75 award is for the supply of Pfizer COVID-19 vaccines under Emergency Use Authorization (EUA) from May 2023 to May 2024. Amerisourcebergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with DLA Troop Support Medical to provide a comprehensive range...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB24FL0KADelivery Order
This federal contract award, valued at $1,081.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract is for the delivery of Pfizer COVID-19 vaccines, under an Emergency Use Authorization (EUA), with an ultimate completion date of March 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific award appears to be a firm fixed price delivery order placed against the IDC. No set-aside designation was used.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 3/12/24 |